Europe Watch

Gibson, Jane
October 2006
ICIS Chemical Business;10/23/2006, Vol. 1 Issue 40, p10
Trade Publication
The article presents news briefs related to the chemical industry in Europe as of October 23, 2006. Sanofi-Aventis has sold its stake in France's Rhodia. The European Commission is looking at ways to award damages to victims of antitrust cartels. The European Commission has approved state aid to two logistics progammes in the European Union.


Related Articles

  • Europe Watch.  // ICIS Chemical Business Americas;10/23/2006, Vol. 270 Issue 15, p13 

    The article offers an update on the European chemicals sector. Sanofi Aventis has decided to sell its 7.98 percent stake in France's Rhodia for approximately $240 million to French bank BNP. The European Commission is planning to develop ways to award damages to victims of antitrust cartels. The...

  • SANOFI-AVENTIS TO BUILD PHARMA PLANT IN CHINA. Ramesh, Deepti // Chemical Week;5/4/2009, Vol. 171 Issue 12, p23 

    The article unveils the plan of Sanofi-Aventis to invest €31 million to construct a facility at the Hangzhou Binjiang New Development Zone in Hangzhou, China. The plant, which will be used to manufacture cardiovascular and anti-cancer products, is expected to be completed in 2012....

  • ...as EC levies fines on cartel. Beacham, Will // European Chemical News;10/6/2003, Vol. 79 Issue 2071, p7 

    Reports on the move of the European Commission to fine sorbates chemical producers Hoechst, Daicel, Ueno and Nippon Synthetic for operating a price cartel between 1979 and 1996. Amount of fine imposed on the companies; Immunity granted to Chisso of Japan; Market share of the companies in 1995.

  • New once a day, fixed dose antimalarial is now available. Griffin, Anne // BMJ: British Medical Journal (International Edition);3/3/2007, Vol. 334 Issue 7591, p443 

    The article states that the Drugs for Neglected Diseases Initiative, a non-profit product development organization, has developed a fixed dose, once a day antimalarial combination treatment for use in developing countries. The treatment will be a combination of artesunate and amodiaquine and in...

  • Sanofi-Aventis Signs Deal with ThalesNano. Ramesh, Deepti // Chemical Week;6/2/2008, Vol. 170 Issue 17, p27 

    The article reports on the research and development (R&D) contract signed by ThalesNano Inc., a developer of micro-scale flow instruments for chemistry, with Sanofi-Aventis that will focus on continuous process chemistry technologies to reduce drug realization time. The collaboration will study...

  • BUSINESS. Robinson, Simon // European Chemical News;10/25/2004, Vol. 81 Issue 2121, p7 

    Presents business news briefs on issues related to the chemical industry in Europe as of October 25, 2004. Financial performance of pharmaceutical company Sanofi-Aventis for the third quarter; Plan of polyamide producer DSM to build a plant in China in 2005; Financial performance of petroleum...

  • The Commission Strikes at Dawn. Houlton, Sarah // Pharmaceutical Executive;Mar2008, Vol. 28 Issue 3, p16 

    The article reports that European Commission officials have raided numerous pharmaceutical companies to investigate the accusations of high drug prices after their patents expired. The officials were conducting investigations on concerns whether the companies misused the patents system to delay...

  • Sanofi: Time not right to sell off beauty unit.  // WWD: Women's Wear Daily;9/8/1997, Vol. 174 Issue 48, p4 

    Focuses on pharmaceuticals and beauty products company, Sanofi's executive vice president for administration and finance, Jean-Paul Leon's issuance of a statement to clarify French business newspapers report that the company is planning to sell off its beauty division. Overview on Sanofi's...

  • Beauty sales at Sanofi decline 2%.  // WWD: Women's Wear Daily;4/14/1995, Vol. 169 Issue 72, p9 

    Reports on the decline in sales of Sanofi SA's beauty products and fragrances during the first quarter of 1995.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics